Clinical Trials Directory

Trials / Sponsors / Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)
Phase 22024-11-21
CompletedA Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Co
Obesity, Overweight
Phase 22024-08-16
CompletedA Study of CT-868 in Type 1 Diabetes Mellitus
Overweight, Obese, Type 1 Diabetes Mellitus
Phase 22023-10-19
CompletedA Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Type 1 Diabetes
Phase 12023-03-21
CompletedA Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
Obesity, Overweight, Type 2 Diabetes Mellitus
Phase 22022-02-22
CompletedA Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Diabetes
Phase 12021-07-16
CompletedA Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus
Diabetes
Phase 12021-04-29